ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.
Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.
Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.
Bush Appoints Seven to NCAB, Designates Runowicz as Chairman.
IOM Report Recommends Solutions to Problem of Medication Errors.
Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - In The Headlines: Private funding can’t replace federal funding—but it can help